Additional research is needed to explore the molecular pathways underlying GSTP1 methylation in HCC, as well as its potential interaction with other oncogenic pathways, such as those involving p53, NF-kB, and TGF-β signaling (Cui et al., 2006). The gene discussed is TP53; the disease is hepatocellular carcinoma.